Furthermore, a difference in levels of cyclin B1, an indicator of the outcome of cell cycle delay induced by Aurora A kinase inhibitor alisertib, was also observed in double-mutant colorectal cancer cell lines. The gene discussed is AURKA; the disease is colorectal cancer.